A probe into the death of New York Rangers prospect Alexei Cherepanov has concluded that team doctors are not to blame for the sudden passing of the 19-year-old.
According to the report, doctors with Cherepanov’s team Avangard Omsk couldn’t have suspected he suffered a chronic heart problem and that they did not prescribe Cherepanov with the medicine he was taking at the time.
The team doctors will not face criminal investigation.
On Oct. 13, 2008, Cherepanov collapsed on the bench after a shift. The autopsy showed Cherepanov suffered from myocarditis, a condition that obstructs blood flow to the heart and other organs.
“Avangard team doctors not only could not have diagnosed Cherepanov with chronic myocarditis while he was living, but could not have even suspected it,” the statement said.
The Investigative Committee concluded in December after analyzing the rising star’s blood and urine samples that Cherepanov had engaged in doping for several months leading up to his death. However, the statement on Thursday revealed he had been taking cordiaminum, which stimulates blood circulation and breathing, suggesting he was taking it to treat his condition.
Avangard’s president, GM and team doctor were suspended indefinitely and another doctor was suspended for two years after the incident, while the president of the host club that evening, Vityaz, was suspended indefinitely after complaints of a lack of medical services in the arena arose.
Nobody has been charged in connection with Cherepanov’s death.